Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3727/105221615X14399878166078 http://scihub22266oqcxt.onion/10.3727/105221615X14399878166078 C4689200!4689200!26637395     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Gene+Expr 2015 ; 16 (4): 155-62 Nephropedia Template TP {{tp|p=26637395|t=2015. Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis |pdf=|usr=}}{{26637395}} gab.com Text Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis JO: Gene Expr http://www.kidney.de/pget.php?&tw=1&pmid=26637395 #FOAvip Noncoding RNAs (ncRNAs) including microRNAs (miRNAs) regulate gene expression at the posttranscriptional level, whereas long coding RNAs (lncRNAs) modulate gene expression both at transcriptional and posttranscriptional levels in mammals. Accumulated evidence demonstrates the widespread aberrations in ncRNA expression associated with almost all types of liver disease. However, the role of ncRNAs in liver fibrosis is poorly understood. Liver fibrosis is the process of excessive accumulation of extracellular matrix (ECM) proteins in the liver that lead to organ dysfunction and tumorigenesis. In this review, we summarize the current knowledge on the role of ncRNAs in promoting or repressing liver fibrosis caused by nonviral agents, potential use of circulating miRNAs as biomarkers of liver fibrosis, and therapeutic approaches to treat liver fibrosis by targeting the dysregulated miRNAs. Twit Text FOAVip Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis ????Gene Expr http://www.kidney.de/pget.php?&tw=1&pmid=26637395 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26637395 #FOAvip English Wikipedia <ref>{{Cite pmid|26637395}}</ref> Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis #MMPMID26637395 Teng KY; Ghoshal K Gene Expr 2015[]; 16 (4): 155-62 PMID26637395show ga Noncoding RNAs (ncRNAs) including microRNAs (miRNAs) regulate gene expression at the posttranscriptional level, whereas long coding RNAs (lncRNAs) modulate gene expression both at transcriptional and posttranscriptional levels in mammals. Accumulated evidence demonstrates the widespread aberrations in ncRNA expression associated with almost all types of liver disease. However, the role of ncRNAs in liver fibrosis is poorly understood. Liver fibrosis is the process of excessive accumulation of extracellular matrix (ECM) proteins in the liver that lead to organ dysfunction and tumorigenesis. In this review, we summarize the current knowledge on the role of ncRNAs in promoting or repressing liver fibrosis caused by nonviral agents, potential use of circulating miRNAs as biomarkers of liver fibrosis, and therapeutic approaches to treat liver fibrosis by targeting the dysregulated miRNAs. äRole of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver (epmc).pdf DeepDyve Pubget Overpricing